http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6166081-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491f932620f41e160e2719b40c91b16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ee6a9749961a3b59e2be12daaf056c
publicationDate 2000-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6166081-A
titleOfInvention Methods and apparatus for treatment of Parkinson's disease
abstract A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enhancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300033-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6746688-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007003621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463186-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007148238-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008051459-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008079404-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008079404-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010316712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426376-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328044-B2
priorityDate 1997-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5474783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5354885-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129335251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23693948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265

Total number of triples: 53.